For GSA community members taking Erivdege, we have received this official statement from Genentech.
Patient safety is Genentech’s highest priority and we are closely monitoring the COVID-19 situation to learn how it may affect people who take our medicines. COVID-19 is a new strain of coronavirus so knowledge about how it may affect people being treated with Erivedge is currently unavailable. There is also no data that demonstrates how Erivedge may affect the immune system. Individuals should speak with their healthcare professionals to determine how Erivedge may affect them or if they should continue treatment with it.